These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1423259)

  • 1. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.
    Butler WB; Fontana JA
    Cancer Res; 1992 Nov; 52(22):6164-7. PubMed ID: 1423259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
    Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7).
    Butler WB; Kirkland WL; Gargala TL; Goran N; Kelsey WH; Berlinski PJ
    Cancer Res; 1983 Apr; 43(4):1637-41. PubMed ID: 6682006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
    Butler WB; Kelsey WH; Goran N
    Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13.
    Strobl JS; Peterson VA
    J Pharmacol Exp Ther; 1992 Oct; 263(1):186-93. PubMed ID: 1403784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
    Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
    Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth-inhibitory action of an estrogen-chlorambucil conjugate (KM2210) in human breast cancer cell line MCF-7: its relation to reduction of estrogen receptor and transforming growth factor-alpha secretion.
    Kosano H; Kubota T; Ohsawa N; Yamamori S; Abe O; Inagaki H; Nagata N
    Cancer Res; 1992 Mar; 52(5):1187-91. PubMed ID: 1737378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
    Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
    Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L; Gudas LJ
    J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M; Bicknell R; Harris AL
    Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells.
    Gierthy JF; Lincoln DW; Roth KE; Bowser SS; Bennett JA; Bradley L; Dickerman HW
    J Cell Biochem; 1991 Feb; 45(2):177-87. PubMed ID: 2055945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of retinoic acid on proliferation of estrogen-responsive transformed murine Leydig cells in serum-free culture.
    Hirose T; Koga M; Kouhara H; Kishimoto S; Matsumoto K; Sato B
    Cancer Res; 1990 Aug; 50(16):5060-4. PubMed ID: 2165854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
    Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH
    Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.